DAMIAN DELBART; GERMÁN GIRI; AGOSTINA CAMMARATA; MELISAN DENISE PAN; LIZETH ARIZA BAREÑO; NATALIA AMIGO; ANDRES BECHIS; ALEJANDRA SUAREZ; ROLANDO SPANEVELLO; MARCELA SOLANGE VILLAVERDE; LAURA B. TODARO; ALEJANDRO J. URTREGER

Antineoplastic activity of products derived from cellulose-containing materials. Levoglucosenone and structurally-related derivatives as new alternatives for breast cancer treatment

INVESTIGATIONAL NEW DRUGS; Lugar: Berlin; Año: 2022 vol. 40 p. 30 - 41

DAMIAN E. BERARDI; LIZETH ARIZA BAREÑO; NATALIA AMIGO; LUCIANA CAÑONERO; MARIA DE LAS NIEVES PELAGATTI; ANDREA NORA MOTTER; MARÍA AGUSTINA TARUSELLI; MARIA I. DIAZ BESSONE; STÉFANO M. CIRIGLIANO; ALEXIS EDELSTEIN; MARÍA GISELLE PETERS; MIRIAM DIAMENT; ALEJANDRO J. URTREGER; LAURA B. TODARO

All-trans retinoic acid and protein kinase C a/b1 inhibitor combined treatment targets cancer stem cells and impair breast tumor progression

Scientific Reports; Lugar: Londres; Año: 2021 vol. 11 p. 6044 - 6061

MACARENA GUEREÑO; MAGALI DELGADO PASTORE; ANA CLARA LUGONES; MAGALI CERCATO; LAURA TODARO; ALEJANDRO J. URTREGER; MARÍA GISELLE PETERS

Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation

EUROPEAN JOURNAL OF CELL BIOLOGY; Año: 2020 vol. 99 p. 1 - 11

MARIA I. DIAZ BESSONE; DAMIAN E. BERARDI; STÉFANO M. CIRIGLIANO; DAMIAN DELBART; MARÍA GISELLE PETERS; LAURA B. TODARO; ALEJANDRO J. URTREGER

Protein Kinase C Alpha (PKCa) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARb) activation in mammary cancer cells

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: Berlin; Año: 2020 vol. 146 p. 3241 - 3253

MILENI SOARES MACHADO; ALEJANDRA G. PALMA; LAURA C. PANELO; LEONARDO A. PAZ; FRANCISCO D. ROSA; MARÍA C. LIRA; PABLO AZURMENDI; MARÍA F. RUBIO; GUIDO LENZ; ALEJANDRO J. URTREGER; MÓNICA A. COSTAS

Extract from Aloysia polystachya induces the cell death of colorectal cancer stem cells

NUTRITION AND CANCER; Lugar: Londres; Año: 2020 vol. 72 p. 1004 - 1017

LAURA C. PANELO; MILENI SOARES MACHADO; MARÍA F. RUBIO; FELIPE JAWORSKI; CECILIA V. ALVARADO; LEONARDO A. PAZ; ALEJANDRO J. URTREGER; ELBA VAZQUEZ; MÓNICA A. COSTAS

High RAC3 expression levels are required for induction and maintaining of cancer cell stemness

ONCOTARGET; Lugar: Albany; Año: 2018 vol. 9 p. 5848 - 5860

MILENI SOARES MACHADO; LAURA C. PANELO; FRANCISCO D. ROSA; MARÍA C. LIRA; CECILIA V. ALVARADO; ALEJANDRO J. URTREGER; MARÍA F. RUBIO; MÓNICA A. COSTAS

The inflammatory cytokine TNF contributes with RAC3-induced malignant transformation

EXCLI JOURNAL; Lugar: Mainz; Año: 2018 vol. 17 p. 1030 - 1042

FERNANDO BENAVENT ; CARLA S. CAPOBIANCO; JUAN GARONA; STÉFANO M. CIRIGLIANO; YASSER PERERA; ALEJANDRO J. URTREGER; SILVIO PEREA; DANIEL F. ALONSO ; HERNAN G. FARINA

CIGB-300, an anti-CK2 peptide, inhibits angiogenesis,tumor cell invasion and metastasis in lung cancer models

LUNG CANCER; Lugar: Amsterdam; Año: 2017 vol. 107 p. 14 - 21

STÉFANO M. CIRIGLIANO; MARÍA INÉS DÍAZ BESSONE; DAMIAN E. BERARDI; CAROLINA FLUMIAN; ELISA D. BAL DE KIER JOFFE; SILVIO PEREA; HERNAN G. FARINA; LAURA B. TODARO; ALEJANDRO J. URTREGER

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines

CANCER CELL INTERNATIONAL; Lugar: Londres; Año: 2017 vol. 17

LEANDRO VENTURUTTI; LUCIA V. ROMERO; ALEJANDRO J. URTREGER; MARÍA F. CHERVO; ROSALÍA I. CORDO RUSSO; MARÍA F. MERCOGLIANO; GLORIA INURRIGARRO; MATÍAS G. PEREYRA; CECILIA J. PROIETTI; FRANCO IZZO; MARÍA C. DÍAZ FLAQUÉ; VICTORIA SUNDBLAD; JUAN C. ROA; PABLO GUZMÁN; ELISA D. BAL DE KIER JOFFE; EDUARDO H. CHARREAU; ROXANA SCHILLACI; PATRICIA V. ELIZALDE

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis

ONCOGENE; Lugar: New York; Año: 2016 vol. 35 p. 2208 - 2222

MERCE MATEU-JIMENEZ; CLARA FERMOSELLE; FEDERICO ROJO; JAVIER MATEU; RAUL PEÑA; ALEJANDRO J. URTREGER; MIRIAM J. DIAMENT; ELISA D. BAL DE KIER JOFFE; LARA PIJUAN; ANTONIO GARCÍA DE HERREROS; ESTHER BARREIRO

Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology

CURRENT PHARMACEUTICAL DESIGN.; Lugar: Oak Park; Año: 2016 vol. 22 p. 5300 - 5310

DAMIAN E. BERARDI; CAROLINA FLUMIAN; CRISTINA E. RODRIGUEZ; MARIA I. DIAZ BESSONE; STÉFANO M. CIRIGLIANO; ELISA D. BAL DE KIER JOFFE; GABRIEL FISZMAN; LAURA B. TODARO; ALEJANDRO J. URTREGER

PKCd inhibition impairs mammary cancer proliferative capacity but selects cancer stem cells, involving autophagy.

JOURNAL OF CELLULAR BIOCHEMISTRY; Lugar: New York; Año: 2016 vol. 117 p. 730 - 740

DAMIAN E. BERARDI; CAROLINA FLUMIAN; PAOLA B. CAMPODÓNICO; ALEJANDRO J. URTREGER; MARIA I. DIAZ BESSONE; ANDREA MOTTER; ELISA BAL DE KIER JOFFÉ; EDUARDO F. FARIAS; LAURA B. TODARO

Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid

CELLULAR ONCOLOGY; Lugar: Dordrecht; Año: 2015 vol. 38 p. 289 - 305

DAMIAN E. BERARDI; MARIA I. DIAZ BESSONE; ANDREA MOTTER; ELISA D. BAL DE KIER JOFFÉ; LAURA B. TODARO; ALEJANDRO J. URTREGER

Involvement of protein kinase C a and d activities on the induction of the retinoic acid system in mammary cancer cells

MOLECULAR CARCINOGENESIS.; Lugar: New York; Año: 2015 vol. 54 p. 1110 - 1121

ALBA CHACON-CABRERA; CLARA FERMOSELLE; ALEJANDRO J. URTREGER; MERCE MATEU-JIMENEZ; MIRIAM J. DIAMENT; ELISA D. BAL DE KIER JOFFE; MARCO SANDRI; ESTHER BARREIRO

Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness

JOURNAL OF CELLULAR PHYSIOLOGY; Lugar: New York; Año: 2014 vol. 229 p. 1660 - 1672

STÉFANO M. CIRIGLIANO; LAURA V. MAURO; VALERIA C. GROSSONI; LUCAS L. COLOMBO; MIRIAM J. DIAMENT; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ; LYDIA I. PURICELLI; ALEJANDRO J. URTREGER

Modulation of pancreatic tumor potential by overexpression protein kinase C beta1 (PKCb1)

PANCREAS.; Lugar: Hagerstown; Año: 2013 vol. 42 p. 1060 - 1069

CLARA FERMOSELLE; ELENA GARCÍA-ARUMÍ; ANTONI L. ANDREU; FRANCISCO SANCHEZ; ESTER PUIG-VILANOVA; ALEJANDRO J. URTREGER; ELISA D. BAL DE KIER JOFFÉ; ALBERTO TEJEDOR; LUÍS PUENTE-MAESTU; ESTHER BARREIRO

Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice

EXPERIMENTAL PHYSIOLOGY.; Lugar: Londres; Año: 2013 vol. 98 p. 1349 - 1365

ALEJANDRO J. URTREGER; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ

Contribution of individual PKC isoforms in the development and promotion of breast cancer malignancy

IUBMB LIFE; Lugar: Boston; Año: 2012 vol. 64 p. 18 - 26

DAMIAN E. BERARDI; MARÍA INÉS DÍAZ BESSONE; ALEJANDRO J. URTREGER; LAURA B. TODARO

Autophagy: friend or foe in breast cancer development, progression and treatment

International Journal of Breast Cancer; Lugar: Londres; Año: 2011 vol. 2011 p. 1 - 7

MARÍA INÉS DÍAZ BESSONE; DAMIAN E. BERARDI; PAOLA B. CAMPODÓNICO; LAURA B. TODARO; LEONARD LOTHSTEIN; ELISA D. BAL DE KIER JOFFÉ; ALEJANDRO J. URTREGER

Involvement of PKC delta (PKCd) in the resistance against doxorubicin analogues

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Dordrecht; Año: 2011 vol. 126 p. 577 - 587

FEDERICO COLUCCIO LESKOW; MARTIN A. KRASNAPOLSKI; ALEJANDRO J. URTREGER

The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients

CURRENT PHARMACEUTICAL BIOTECHNOLOGY; Lugar: Hilversum; Año: 2011 vol. 12 p. 1961 - 1973

LAURA V. MAURO; VALERIA C. GROSSONI; ALEJANDRO J. URTREGER; CHENGFEN YANG; LUCAS L. COLOMBO; ANA MORANDI; MARÍA G. PALLOTA; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ; LYDIA I. PURICELLI

PKC delta (PKCd) promotes tumoral progression of human ductal pancreatic cancer

PANCREAS.; Lugar: Hagerstown; Año: 2010 vol. 39 p. 31 - 41

PAOLA B. CAMPODÓNICO; ELISA D. BAL DE KIER JOFFÉ; ALEJANDRO J. URTREGER; LILIA S. LAURÍA; JOSÉ MARÍA LASTIRI; LYDIA I. PURICELLI; LAURA B. TODARO

The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer

MOLECULAR CARCINOGENESIS.; Lugar: Nueva York; Año: 2010 vol. 49 p. 386 - 397

VALERIA C. GROSSONI; LAURA B. TODARO; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ; ALEJANDRO J. URTREGER

Opposite effects of protein kinase C beta1 (PKCb1) and PKCe in the metastatic potential of a breast cancer murine model

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Dordrecht; Año: 2009 vol. 118 p. 469 - 480

VALERIA C. GROSSONI; KARINA B. FALBO; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFE; ALEJANDRO J. URTREGER

Protein kinase Cd enhances proliferation and survival of murine mammary cells

MOLECULAR CARCINOGENESIS.; Lugar: New York; Año: 2007 vol. 46 p. 381 - 390

VALERIA C. GROSSONI; KARINA B. FALBO; LAURA V. MAURO; MARTIN A. KRASNAPOLSKI; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ; ALEJANDRO J. URTREGER

Protein kinase Cd inhibits the production of proteolytic enzymes in murine mammary cells

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Dordrecht; Año: 2007 vol. 24 p. 513 - 520

ROMINA CARNEVALE; CECILIA PROIETTI; MARIANA SALATINO; ALEJANDRO J. URTREGER; GUILLERMO D. PELUFFO; DEAN P. EDWARDS; VIROJ BOONYARATANAKORNKIT; EDUARDO CHARREAU; ELISA D. BAL DE KIER JOFFÉ; ROXANA SCHILLACI; PATRICIA ELIZALDE

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways

MOLECULAR ENDOCRINOLOGY; Lugar: Baltimore; Año: 2007 vol. 21 p. 1335 - 1358

ALEJANDRO J. URTREGER; SANTIAGO E. WERBAJH; FRANK VERRECCHIA; ALAIN MAUVIEL; LYDIA I. PURICELLI; ALBERTO R. KORNBLIHTT; ELISA D. BAL DE KIER JOFFÉ

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2006 vol. 16 p. 1403 - 1410

ALEJANDRO J. URTREGER; VALERIA C. GROSSONI; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ

Atypical protein kinase C-z modulates clonogenicity, motility and secretion of proteolytic enzymes in murine mammary cells

MOLECULAR CARCINOGENESIS.; Lugar: New York; Año: 2005 vol. 42 p. 29 - 39

VIVIANA BUMASCHNY; ALEJANDRO J. URTREGER; MIRIAM J. DIAMENT; MARTIN A. KRASNAPOLSKI; GABRIEL FISZMAN; SLOBODANKA M. KLEIN; ELISA D. BAL DE KIER JOFFE

Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model

BREAST CANCER RESEARCH; Lugar: Londres; Año: 2004 vol. 6 p. 116 - 129

CECILIA DAROQUI; LYDIA I. PURICELLI; ALEJANDRO J. URTREGER; PATRICIA ELIZALDE; GUILLERMO LANUZA; ELISA D. BAL DE KIER JOFFE

Involvement of TGF-Bs/TBRs system in tumor progression of murine mammary adenocarcinomas

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2003 vol. 80 p. 287 - 301

ALEJANDRO J. URTREGER; MIRIAM J. DIAMENT; STELLA RANUNCOLO; SLOBODANKA M. KLEIN; MARÍA DEL CARMEN VIDAL; LYDIA I. PURICELLI; ELISA D. BAL DE KIER JOFFE

New murine cell line derived from a spontaneous lung tumor induces paraneoplastic syndromes

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2001 vol. 18 p. 639 - 647

ALEJANDRO J. URTREGER; JULIO AGUIRRE-GHISO; LYDIA I. PURICELLI; SANTIAGO E. WERBAJH; ANDRES MURO; ELISA D. BAL DE KIER JOFFE

Involvement of fibronectin in the regulation of urokinase production and binding in murine mammary tumor cells

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1999 vol. 82 p. 748 - 753

SANTIAGO E. WERBAJH; ALEJANDRO J. URTREGER; LYDIA I. PURICELLI; ELISA D. BAL DE KIER JOFFE; ALBERTO R. KORNBLIHTT

Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells

FEBS LETTERS; Lugar: Amsterdam; Año: 1998 vol. 440 p. 277 - 281

ALEJANDRO J. URTREGER; FABIOLA PORRO; SANTIAGO E. WERBAJH; LYDIA I. PURICELLI; ELISA D. BAL DE KIER JOFFE; ALBERTO R. KORNBLIHTT; ANDRES MURO

Expression of RGD minus fibronectin that does not form extracellular matrix fibrills is sufficient to decrease tumor metastasis

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1998 vol. 5 p. 233 - 241

ALEJANDRO J. URTREGER; VIRGINIA LADEDA; MARÍA DEL CARMEN VIDAL; LYDIA I. PURICELLI; EUGENIA SACERDOTE DE LUSTIG; ELISA D. BAL DE KIER JOFFE

Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 1997 vol. 11 p. 489 - 496

DANIEL F. ALONSO; EDUARDO F. FARIAS; ALEJANDRO J. URTREGER; VIRGINIA LADEDA; MARÍA DEL CARMEN VIDAL; ELISA D. BAL DE KIER JOFFE

Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma

JOURNAL OF SURGICAL ONCOLOGY; Año: 1996 vol. 62 p. 288 - 297